Cargando…
Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients
Autores principales: | Fan, N., Lavu, S., Hanson, C. A., Tefferi, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242913/ https://www.ncbi.nlm.nih.gov/pubmed/30455416 http://dx.doi.org/10.1038/s41408-018-0156-6 |
Ejemplares similares
-
Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience
por: Begna, K, et al.
Publicado: (2016) -
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
por: Kjær, Lasse
Publicado: (2020) -
A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy
por: Gangat, Naseema, et al.
Publicado: (2019) -
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts
por: Tefferi, Ayalew, et al.
Publicado: (2018) -
Extramedullary Myeloid Leukemia in the Setting of a Myeloproliferative Neoplasm
por: Kosti, Jorgena, et al.
Publicado: (2022)